MyBlood ApS: Financial statements 2025
CVR: 41668393
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MyBlood ApS (CVR 41668393) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 2,590. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 2,590
- Total Assets
- DKK 2,590
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 0 | 3K | - |
| 2024 | - | 0 | 0 | 3K | - |
| 2023 | - | 0 | 0 | 3K | - |
| 2022 | - | -25K | -25K | 3K | - |
Official annual report
How creditworthy is MyBlood ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
MyBlood ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK 0.
About MyBlood ApS
MyBlood ApS is a Danish company of the type Anpartsselskab based in Vodskov, founded in 2020. The company is registered under the industry Fremstilling af instrumenter og udstyr til måling, afprøvning og navigation. The management consists of Christine Maria Røntved. The company is owned by Christine Maria Røntved and Auste Augustyte. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 2,590.